<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00931437</url>
  </required_header>
  <id_info>
    <org_study_id>08-3-086</org_study_id>
    <nct_id>NCT00931437</nct_id>
  </id_info>
  <brief_title>Vitamin K-absorption From Dairy</brief_title>
  <official_title>Absorption of Different Forms of Vitamin K From Dairy Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lactic acid bacteria produce a mixture of higher menaquinones, including menaquinone-9 (MK-9)
      and menaquinone-10 (MK-10). Vitamin K1 (phylloquinone) is normally present in chloroplasts in
      green vegetables. A new dairy product is developed containing both vitamin K1 and
      K2-vitamins. However, the extent to which the various forms of vitamin K are absorbed from
      such a mixture is not known. In this study the absorption profile of phylloquinone and
      menaquinones from this new dairy product containing several K-vitamins is investigated. This
      study describes a dietary intervention experiment for one single cocktail containing several
      K-vitamins as part of a dairy product.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum vitamin K levels: phylloquinone, menaquinone-7,-8,-9,and -10</measure>
    <time_frame>one single intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>distribution of vitamin K-forms over lipoprotein fractions: triglyceride rich lipoprotein (TGRLP), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), high density lipoprotein (HDL) as well as the lipoprotein-free fraction (LPF)</measure>
    <time_frame>one single intake</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>vitamin K-rich dairy product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one single intake of a dairy product containing several K-vitamins: phylloquinone, menaquinone-7,8,9-and 10.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin K-rich dairy product</intervention_name>
    <description>several forms of vitamin K: phylloquinone, menaquinone-7,-8,-9,and -10.</description>
    <arm_group_label>vitamin K-rich dairy product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women between 20 and 45 years old

          -  Subjects of normal body weight and height according to BMI &lt; 30

          -  Subjects of Caucasian race

          -  Subject has given written consent to take part in the study

        Exclusion Criteria:

          -  Subjects with (a history of) metabolic or gastrointestinal disease

          -  Subjects presenting chronic degenerative and/or inflammatory disease

          -  Abuse of drugs and/or alcohol

          -  Subjects receiving corticoid treatment

          -  Subjects using oral anticoagulants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cees Vermeer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VitaK / University of Maastricht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VitaK BV / University of Maastricht</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2009</study_first_submitted>
  <study_first_submitted_qc>June 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2009</study_first_posted>
  <last_update_submitted>December 15, 2010</last_update_submitted>
  <last_update_submitted_qc>December 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. C. Vermeer</name_title>
    <organization>VitaK BV</organization>
  </responsible_party>
  <keyword>vitamin K</keyword>
  <keyword>Bio-availability</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

